The relationship between 1,25(OH) 2 D 3 levels and interleukin-32 and vascular endothelial growth factor levels in endometriosis cyst tissue: An original article
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
Background: Endometriosis involves the presence of endometrial-like tissue outside the uterus, driven by inflammatory pathways including elevated interleukin-32 and vascular endothelial growth factor. One potential anti-inflammatory agent is active vitamin D (1,25(OH) 2 D 3 ). Objectives: This research investigates the correlation among 1,25(OH) 2 D 3 levels, interleukin-32, and vascular endothelial growth factor in confirmed endometriosis cases. Methods: This observational analytic correlational study aimed to explore the relationship between these inflammatory factors and vitamin D levels in endometriosis. The study involved 46 participants, with histopathologically confirmed endometriosis cyst tissue collected from patients undergoing laparotomy or laparoscopy at three hospitals: Dr. Hasan Sadikin Hospital Bandung, Cibabat General Hospital Cimahi, and Limijati Maternity and Children’s Hospital. The levels of interleukin-32, vascular endothelial growth factor, and 1,25(OH) 2 D 3 were measured using the enzyme-linked immunosorbent assay method at the Clinical Pathology Laboratory of Dr. Hasan Sadikin Hospital Bandung. Results: The study revealed significant negative correlations between 1,25(OH) 2 D 3 and both interleukin-32 ( r = −0.346; p = 0.019) and vascular endothelial growth factor levels ( r = −0.316; p = 0.032). Conversely, there was a significant positive correlation between vascular endothelial growth factor and interleukin-32 ( r = 0.490; p = 0.001). Conclusions: These findings underscore the role of active vitamin D in mitigating inflammation associated with endometriosis by reducing interleukin-32 and vascular endothelial growth factor, critical factors in inflammatory responses and blood vessel formation. Moreover, the positive association between vascular endothelial growth factor and interleukin-32 highlights their collaborative role in the inflammatory processes underlying endometriosis. This study contributes to understanding how vitamin D may modulate key inflammatory pathways implicated in the pathogenesis of this condition.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- 25-Hydroxyvitamin D Serum Levels and Endometriosis: Results of a Case–Control Study via openalex
- Comparison of Menstrual Effluent Vascular Endothelial Growth Factor Immunocytochemistry Expression Between Endometriosis and Non-Endometriosis Patients via openalex
- Endometriosis and Adenomyosis via openalex
- Immunology of Endometriosis via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study via openalex
- p38 Mitogen-Activated Protein Kinase is Involved in the Pathogenesis of Endometriosis by Modulating Inflammation, but not Cell Survival via openalex
- The association of body mass index with endometriosis and disease severity in women with pain via openalex
- The link between immunity, autoimmunity and endometriosis: a literature update via openalex
- The Relationship Between 1,25(OH)2D3 Levels and Interleukin-32 (IL-32) and Vascular Endothelial Growth Factor (VEGF) Levels in Endometriosis Cyst Tissue via openalex
- Understanding the NICE guidance on endometriosis via openalex
- W2518680640 via openalex
- W2169970560 via openalex
- W2994902547 via openalex
- W2057284932 via openalex
- W3134885188 via openalex
- W3166072950 via openalex
- W3180906813 via openalex
- W2007774407 via openalex
- W1975350793 via openalex
- W4214607631 via openalex
- W4214754424 via openalex
- W4234160457 via openalex
- W4285147756 via openalex
- W4287122105 via openalex
- W4298138977 via openalex
- W2604055709 via openalex
- W1970516100 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-05-30T00:31:42.381584+00:00
License: CC0
· commercial use OK